NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to ...
Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...